Patents by Inventor Troy James KAISER

Troy James KAISER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
    Publication number: 20240226264
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: December 27, 2023
    Publication date: July 11, 2024
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
    Patent number: 11896659
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 13, 2024
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
    Publication number: 20230302113
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Application
    Filed: November 23, 2022
    Publication date: September 28, 2023
    Inventors: Arun IYER, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
    Patent number: 11701419
    Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: July 18, 2023
    Inventors: Arun Iyer, Luis Alejandro Hernandez, Abby Patterson, Bailey Arruda, Luis Gabriel Gimenez-Lirola, Dave Michael Anstrom, Eric M. Vaughn, Pablo E. Pineyro Pineiro, Troy James Kaiser, Joseph Ralph Hermann
  • Vaccine against porcine parvovirus
    Patent number: 10799578
    Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: October 13, 2020
    Inventors: Scott Eugene Bucklin, Troy James Kaiser, Jeremy Kroll, Philip Utley, Eric Martin Vaughn
  • Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
    Patent number: 10660952
    Abstract: The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: May 26, 2020
    Inventors: Troy James Kaiser, Jeremy Kroll, Eric Martin Vaughn
  • VACCINE AGAINST PORCINE PARVOVIRUS
    Publication number: 20200030438
    Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Application
    Filed: October 10, 2019
    Publication date: January 30, 2020
    Inventors: Scott Eugene BUCKLIN, Troy James KAISER, Jeremy KROLL, Philip UTLEY, Eric Martin VAUGHN
  • Vaccine against porcine parvovirus
    Patent number: 10485866
    Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: November 26, 2019
    Inventors: Scott Eugene Bucklin, Troy James Kaiser, Jeremy Kroll, Philip Utley, Eric Martin Vaughn
  • VACCINE AGAINST PORCINE PARVOVIRUS AND PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND METHODS OF PRODUCTION THEREOF
    Publication number: 20180147278
    Abstract: The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 31, 2018
    Inventors: Sonja KLOCKE, Robert Thomas COOL, Curtis Robert EDWARDS, Fuad Tawfiq HADDADIN, Gregory Brian HAIWICK, Troy James KAISER, Jeremy KROLL, Sonia Regina Cantisano MALBURG, Marta NOGUERA SERRAT, Merrill Lynn SCHAEFFER, Andrea J. Headrick STARKS, Michael Landon STEWART, Eric Martin VAUGHN, Guosong ZHAO
  • VACCINE AGAINST PORCINE PARVOVIRUS
    Publication number: 20180133309
    Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.
    Type: Application
    Filed: November 2, 2017
    Publication date: May 17, 2018
    Inventors: Scott Eugene BUCKLIN, Troy James KAISER, Jeremy KROLL, Philip UTLEY, Eric Martin VAUGHN
  • SALMONELLA CHOLERAESUIS-SALMONELLA TYPHIMURIUM VACCINES
    Publication number: 20170072042
    Abstract: The present invention relates methods of reducing fecal shedding of animals infected with Salmonella by use of a vaccine or immunogenic composition of Salmonella Choleraesuis-Typhimurium.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: Brian James FERGEN, Dianna M. Murphy JORDAN, Troy James KAISER, Rex Alan SMILEY